SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-014526
Filing Date
2020-03-31
Accepted
2020-03-31 16:00:55
Documents
2
Effectiveness Date
2020-03-31

Document Format Files

Seq Description Document Type Size
1 DEFA14A nvus-defa14a_20200512.htm DEFA14A 31163
2 GRAPHIC gpc33nhpv3vx000001.jpg GRAPHIC 127560
  Complete submission text file 0001564590-20-014526.txt   208098
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36620 | Film No.: 20761742
SIC: 2834 Pharmaceutical Preparations